DuPont Leasing Space to Incyte Genomics
March 06, 2002 — Delaware state officials announced Monday that Incyte Genomics, Inc., headquartered in Palo Alto, California, has signed a lease agreement with DuPont to locate its first East Coast biotechnology research operation in the Stine-Haskell Research Center in Newark, Delaware. Incyte plans to occupy the space this month and initially will lease up to 50,000 square feet of the Stine-Haskell Research Center, a DuPont site, located on Elkton Road.
Delaware Governor Ruth Ann Minner said she is "pleased that DuPont is a partner with the state in finding an ideal location for Incyte."
DuPont Senior Vice President Stacey Mobley, who chairs the Delaware Governor's Strategic Economic Council, said, "In order for Delaware to remain economically healthy, the state needs to attract new industry, as well as grow the businesses that are already here. We welcome Incyte to the Delaware business community."

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Nosema_ceranae
Pall Systems Play Key Role in Landmark NIH Study on Cord Blood
Category:Czech_physiologists
Hepatitis

The Art of Sensing within the Skin - Dermal tattoo sensors for the detection of blood pH change and metabolite levels

New tool helps to ‘spot the difference’ in genome organisation - This enables scientists to track down causes of diseases more quickly
Genzyme Presents New Data from Alemtuzumab Phase 2 MS Trial
Equine_polysaccharide_storage_myopathy
Gene-for-gene_relationship
